HESI Pharmacology IV Exam

Correct answer C: Serum creatinine

Explanation of the correct answer:

C. Serum creatinine

Foscarnet is an antiviral medication used to treat cytomegalovirus (CMV) retinitis and other viral infections, particularly in immunocompromised patients, such as those with acquired immunodeficiency syndrome (AIDS). One of the most important side effects of foscarnet is nephrotoxicity (kidney damage), which can result in elevated serum creatinine levels. Therefore, it is crucial to monitor serum creatinine regularly to assess kidney function and prevent renal complications while the client is on foscarnet therapy.

Why the other options are incorrect:

A. CD4 cell count

While monitoring CD4 cell count is important in managing HIV/AIDS, it is not the most urgent parameter to monitor for a client taking foscarnet. The primary concern with foscarnet therapy is renal function, so serum creatinine is more critical in this context.

B. Serum albumin

Serum albumin is an indicator of nutritional status and liver function, but it is not directly related to the nephrotoxic effects of foscarnet. Serum creatinine is the more relevant lab value for monitoring the client’s renal function during foscarnet therapy.

D. Lymphocyte count

The lymphocyte count is part of the immune status of the client and is important for monitoring the progression of HIV/AIDS. However, it is not specifically related to the renal toxicity associated with foscarnet, which is why it is not the priority laboratory value to check for clients on this medication.

Summary:

The nurse should monitor serum creatinine in a client receiving foscarnet due to the potential risk of nephrotoxicity. This is the most critical laboratory test for assessing renal function and preventing complications while on foscarnet therapy.

Correct Answer D: One hour before meals and at bedtime

Explanation of the Correct Answer:

D. One hour before meals and at bedtime is correct because sucralfate (Carafate) works best when taken on an empty stomach, as it forms a protective barrier over the ulcer, preventing further irritation. The optimal timing for sucralfate is one hour before meals and at bedtime. Taking the medication at these times maximizes its effectiveness in protecting the stomach lining and promoting healing.

Why the other options are incorrect:

A. With meals and at bedtime

is incorrect because sucralfate should be taken before meals, not with meals. When taken with meals, the medication may not adhere as effectively to the ulcer, reducing its protective effect.

B. Every 6 hours around the clock

is incorrect because sucralfate should not be taken at regular intervals like this. The medication should be taken before meals and at bedtime, as this ensures the drug has adequate time to work and form a protective barrier on the ulcer.

C. One hour after meals and at bedtime

is incorrect because sucralfate should be taken before meals, not after. Taking it after meals could interfere with its ability to coat the ulcer properly, as food may already be present in the stomach.

Summary:

The optimal timing for sucralfate (Carafate) is one hour before meals and at bedtime. This schedule ensures that the medication is most effective at forming a protective coating over the ulcer, helping to promote healing. Taking it with or after meals may reduce the medication's effectiveness.

Correct Answer C: Liver enzyme levels.

Explanation of the Correct Answer:

C. Liver enzyme levels

Isoniazid (INH) is a medication commonly used in the treatment of tuberculosis. It is known to potentially cause hepatotoxicity, which can lead to liver damage. Before initiating treatment with INH, the nurse must ensure that liver enzyme levels (such as AST, ALT, and bilirubin) have been assessed to establish a baseline and to monitor for any signs of liver toxicity during treatment. This is a critical step because liver function tests help in detecting early signs of liver damage and guide further management of the medication.

Why the Other Options Are Incorrect:

A. Electrolyte levels

While monitoring electrolyte levels is important for certain medications, it is not a priority baseline test for a client starting INH therapy. INH does not commonly cause electrolyte disturbances that would require baseline testing. The primary concern with INH is its potential for liver toxicity, which is why liver enzyme levels are more important.

B. Coagulation times

Coagulation tests (such as PT/INR) are typically monitored in patients taking anticoagulant therapy or those with liver dysfunction affecting vitamin K metabolism. INH does not generally affect coagulation directly, so this is not the baseline study required for starting INH therapy.

D. Serum creatinine level

A serum creatinine level is usually assessed to evaluate renal function, but renal toxicity is not a primary concern with INH. INH's main side effect is hepatotoxicity, so monitoring liver enzyme levels is the most relevant baseline study.

Summary:

Before starting isoniazid (INH) therapy for tuberculosis, it is essential to complete liver enzyme tests to establish a baseline for liver function, as the medication has the potential to cause hepatotoxicity. Monitoring liver function is critical throughout the treatment to detect any early signs of liver damage.

Correct answer B: Atropine sulfate

Explanation of the correct answer:

B. Atropine sulfate

In a cholinergic crisis, which can occur when a client with myasthenia gravis receives too much of an anticholinesterase medication like pyridostigmine, there is an excessive accumulation of acetylcholine at the neuromuscular junction and muscarinic receptors. This overstimulation of the parasympathetic nervous system results in life-threatening symptoms such as bradycardia, hypotension, respiratory distress, bronchial secretions, increased salivation, sweating, nausea, vomiting, diarrhea, and muscle weakness. These are classic signs of cholinergic toxicity.

Atropine sulfate is a competitive antagonist of muscarinic acetylcholine receptors, meaning it blocks the effects of acetylcholine in the parasympathetic nervous system. By doing so, atropine reverses the muscarinic symptoms of a cholinergic crisis such as bradycardia, bronchospasm, and excessive secretions. It does not reverse the nicotinic effects like muscle weakness or paralysis, but it can rapidly stabilize cardiovascular and respiratory functions, which are critical in preventing complications like respiratory failure or cardiovascular collapse. For this reason, atropine must be readily available in care settings where clients receive anticholinesterase therapy.

Why the other options are incorrect:

A. Vitamin K

Vitamin K is primarily used as the antidote for warfarin (Coumadin) overdose. Warfarin is an anticoagulant that interferes with the synthesis of vitamin K-dependent clotting factors. In cases of excessive anticoagulation or bleeding caused by warfarin, vitamin K restores the body’s ability to clot. It does not interact with acetylcholine or anticholinesterase medications and has no role in the treatment of cholinergic crisis.

C. Protamine sulfate

Protamine sulfate is used as the antidote to neutralize the effects of heparin, another anticoagulant. It works by binding to heparin and forming a stable complex that prevents its anticoagulant activity. Protamine has no effect on cholinergic receptors and is therefore not useful in treating cholinergic toxicity or symptoms resulting from pyridostigmine overdose.

D. Acetylcysteine (Mucomyst)

Acetylcysteine is primarily used to treat acetaminophen (Tylenol) overdose by replenishing glutathione, a substance needed to detoxify the liver. It is also used as a mucolytic to help loosen thick mucus in conditions like cystic fibrosis or chronic bronchitis. Acetylcysteine does not interact with acetylcholine and has no antidotal properties for cholinergic toxicity. It is not appropriate for use in cholinergic crisis.

Summary:

Atropine sulfate is the most appropriate medication to have available in the event of a cholinergic crisis in a client receiving pyridostigmine. It counteracts the muscarinic effects of acetylcholine overdose, such as bradycardia, bronchospasm, and hypotension, making it essential for emergency intervention. The other options—vitamin K, protamine sulfate, and acetylcysteine—are specific antidotes for other drug toxicities and do not address the underlying pathophysiology of cholinergic crisis.

Correct Answer B: Checking the frequency and consistency of bowel movements

Explanation of the Correct Answer:

B Checking the frequency and consistency of bowel movements is correct because infliximab (Remicade) is an immunosuppressive medication used to treat inflammatory bowel diseases like Crohn's disease. One of the primary therapeutic goals of infliximab is to reduce inflammation in the intestines, thereby improving symptoms such as diarrhea and abdominal pain. Monitoring the frequency and consistency of bowel movements is an effective way to assess the medication's impact on the client's condition, as improvement would be reflected by a decrease in the frequency and normalization of stool consistency.

Why the other options are incorrect:

A. Monitoring the leukocyte count for 2 days after the infusion

is incorrect because while leukocyte count can be monitored to detect infections or immunosuppression, it is not a specific indicator of infliximab's effectiveness for treating Crohn's disease. The primary goal is to manage symptoms like bowel frequency, not just the white blood cell count.

C. Checking serum liver enzyme levels before and after the infusion

is incorrect because while liver function should be monitored as part of routine care with infliximab due to the potential for hepatotoxicity, changes in liver enzymes are not directly linked to the effectiveness of the treatment for Crohn's disease. Monitoring liver enzymes is a safety measure rather than a specific measure of infliximab’s therapeutic effect.

D. Carrying out a Hematest on gastric fluids after the infusion is completed

is incorrect because the Hematest is used to detect occult blood in the stool, typically for assessing gastrointestinal bleeding, not for monitoring the effectiveness of infliximab treatment. While Crohn's disease can cause intestinal bleeding, this test is not the primary method for evaluating the success of infliximab therapy.

Summary:

To monitor the effectiveness of infliximab in treating Crohn's disease, the nurse should focus on changes in bowel movements, as this directly reflects the reduction in symptoms such as diarrhea and abdominal discomfort. While other parameters like leukocyte count and liver enzyme levels are important for safety, they do not directly measure the medication’s impact on Crohn’s disease symptoms.

Correct answer C: Hearing loss

Explanation of the correct answer:

C. Hearing loss

Amikacin (Amikin) is an aminoglycoside antibiotic that can cause ototoxicity (damage to the ear, leading to hearing loss) as a serious side effect. Hearing loss or tinnitus (ringing in the ears) are potential signs of ototoxicity, which can occur with aminoglycosides like amikacin. Because this is a potentially irreversible and serious side effect, the client should contact the healthcare provider immediately if they experience hearing loss during treatment.

Why the other options are incorrect:

A. Nausea

While nausea can be a common side effect of many medications, including amikacin, it is generally not an indication for immediate contact with the healthcare provider unless it is severe or accompanied by other symptoms. Nausea can be managed and is not typically a sign of a serious adverse reaction that requires urgent attention.

B. Lethargy

Lethargy can be a side effect of many medications, including amikacin, but it is usually not as urgent as hearing loss. However, if lethargy becomes severe or is accompanied by other concerning symptoms, the healthcare provider should be contacted. Still, hearing loss is the primary urgent issue in this scenario.

D. Muscle aches

Muscle aches (myalgia) are not common side effects of amikacin, and they are typically not urgent unless accompanied by other severe symptoms like rhabdomyolysis. However, hearing loss due to ototoxicity is more concerning and requires immediate medical attention.

Summary:

Clients taking amikacin (Amikin) should contact their healthcare provider immediately if they experience hearing loss, as this could indicate ototoxicity, a serious side effect that may be irreversible.

Correct Answer D: Orange juice

Explanation of the Correct Answer:

D. Orange juice is correct because it is high in vitamin C (ascorbic acid), which enhances the absorption of oral iron from the gastrointestinal tract. Iron is better absorbed in an acidic environment, and vitamin C-rich foods or beverages like orange juice help to increase iron bioavailability, making the treatment more effective in managing iron deficiency anemia.

Why the other options are incorrect:

A. Milk is incorrect because it contains calcium and casein, both of which can inhibit iron absorption. Additionally, dairy products in general reduce the bioavailability of iron and should not be given with oral iron supplements.

B. Water is incorrect because, although it does not inhibit iron absorption, it also does not enhance it. Water is neutral and lacks the acidic or vitamin C content needed to improve iron absorption, making it less effective than orange juice in this context.

C. Apple juice is incorrect because while it may contain a small amount of vitamin C, it is not nearly as effective as orange juice in enhancing iron absorption. Some varieties are low in ascorbic acid and may even contain substances like phytates that hinder absorption.

Summary:

When administering oral iron supplements to a child with iron deficiency anemia, the best choice is to give it with orange juice. Orange juice improves iron absorption due to its high vitamin C content. Milk and apple juice may impair absorption, and water, while neutral, does not aid absorption. Therefore, orange juice is the best choice to maximize the effectiveness of oral iron therapy.

Correct Answer B: To return to the clinic weekly for serum drug-level testing.

Explanation of the Correct Answer:

B. To return to the clinic weekly for serum drug-level testing.

Cycloserine (Seromycin) is an antitubercular medication that requires regular monitoring of serum drug levels due to its potential for toxicity, especially affecting the central nervous system (CNS). CNS side effects such as seizures, confusion, or mood changes can occur with cycloserine, and monitoring drug levels helps to ensure that they stay within a therapeutic range and to avoid these severe effects. Therefore, the nurse should include weekly testing for drug levels in the client's teaching plan.

Why the Other Options Are Incorrect:

A. To take the medication before meals.

Cycloserine does not specifically require administration before meals. The medication can be taken with or without food, but it is important to follow the exact prescription instructions given by the healthcare provider regarding timing. There is no need to instruct the client to take it specifically before meals unless directed.

C. It is not necessary to call the health care provider (HCP) if a skin rash occurs.

A skin rash could be a sign of a serious allergic reaction or other side effects of cycloserine, such as hypersensitivity reactions. It is essential to call the HCP if a rash occurs, especially since some reactions could be severe. This statement is incorrect because the nurse should instruct the client to notify the healthcare provider immediately if any rash or allergic symptoms develop.

D. It is not necessary to restrict alcohol intake with this medication.

This statement is incorrect because alcohol should be restricted when taking cycloserine due to the risk of increased CNS toxicity. Both alcohol and cycloserine can have CNS depressant effects, and combining them can lead to dangerous neurological side effects. Therefore, the client should be instructed to avoid alcohol while on cycloserine.

Summary:

The client receiving cycloserine (Seromycin) should return to the clinic weekly for serum drug-level testing to ensure the medication is within a safe therapeutic range. Other key points for client teaching include avoiding alcohol and reporting any skin rash to the healthcare provider.

Correct Answer B: 0.5 to 2 ng/mL

Explanation of the Correct Answer:

B. 0.5 to 2 ng/mL

The therapeutic serum digoxin level range is 0.5 to 2 ng/mL. Digoxin has a narrow therapeutic range, and monitoring blood levels is essential to ensure the drug is effective without causing toxicity. The serum level outside of this range, especially higher levels, increases the risk for digoxin toxicity, which can be life-threatening.

Why the Other Options Are Incorrect:

A. 3 to 5 ng/mL

This range is above the therapeutic range for digoxin and suggests toxicity. Levels higher than 2 ng/mL are considered too high and increase the risk of toxicity, particularly when combined with factors like hypokalemia.

C. 1.2 to 2.8 ng/mL

Although the upper part of this range (2.8 ng/mL) is close to the therapeutic range, the 1.2 to 2.8 ng/mL range is too broad and slightly exceeds the ideal therapeutic range for digoxin, which is considered 0.5 to 2 ng/mL.

D. 3.5 to 5.5 ng/mL

This range is well above the therapeutic range for digoxin and indicates toxicity. Digoxin toxicity can result in serious effects such as arrhythmias, anorexia, nausea, vomiting, and visual disturbances.

Summary:

The therapeutic serum level for digoxin is 0.5 to 2 ng/mL. Levels above this range increase the risk of digoxin toxicity, which is a serious concern. The nurse should be vigilant in monitoring digoxin levels and serum potassium levels, as hypokalemia can predispose a client to digoxin toxicity.